synriam
Ranbaxy Unveils Synriam: India’s First Anti-Malarial Drug
India’s Ranbaxy Laboratories Limited has launched the country’s first indigenously-developed anti-malarial drug, Synriam.
India’s Ranbaxy Laboratories Limited has launched the country’s first indigenously-developed anti-malarial drug, Synriam.
